Start Forschung Personen Publikationen

Publikationen

Prof. Dr. Karl F. Mann

Anton RF, Witkiewitz K, Falk D, Litten R, Hasin D, Mann K, O'Malley S, Alcohol Clinical Trial Workgroup (ACTIVE) . Response to Dr. Mark Litt's Commentary. Alcohol Clin Exp Res. 2019 Aug 5. [Epub ahead of print]
Aubin HJ, Mann K. Medication development: reducing casualties in the valley of death and providing support for survivors. Alcohol Clin Exp Res. 2019 43(1):22-52. Epub 2018 Nov 11.
Bach P, Weil G, Pompili E, Hoffmann S, Hermann D, Vollstädt-Klein S, Mann K, Perez-Ramirez U, Moratal D, Canals S, Dursun SM, Greenshaw AJ, Kirsch P, Kiefer F, Sommer WH. Incubation of neural alcohol cue reactivity after withdrawal and its blockade by naltrexone. Addict Biol. 2019 Feb 12. [Epub ahead of print]
Chaarani B, Kan KJ, Mackey S, Spechler PA, Potter A, Orr C, D'Alberto N, Hudson KE, Banaschewski T, Bokde AL, Bromberg U, Büchel C, Cattrell A, Conrod PJ, Desrivieres S, Flor H, Frouin V, Gallinat J, Gowland P, Heinz A, Ittermann B, Martinot JL, Nees F, Papadopoulos-Orfanos D, Paus T, Poustka L, Smolka MN, Walter H, Whelan R, Higgins ST, Schumann G, Althoff RR, Stein EA, Garavan H, Mann KF, Rietschel M, Spanagel R, Millenet S, IMAGEN Consortium . Low Smoking Exposure, the Adolescent Brain, and the Modulating Role of CHRNA5 Polymorphisms. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 4(7):672-679. Epub 2019 Mar 15.
Falk DE, O'Malley SS, Witkiewitz K, Anton RF, Litten RZ, Slater M, Kranzler HR, Mann KF, Hasin DS, Johnson B, Meulien D, Ryan M, Fertig J, Alcohol Clinical Trials Initiative (ACTIVE) Workgroup . Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials. JAMA Psychiatry. 2019 76(4):374-381. Epub 2019 Mar 13.
Knox J, Scodes J, Wall M, Witkiewitz K, Kranzler HR, Falk D, Litten R, Mann K, O'Malley SS, Anton R, Hasin DS, Alcohol Clinical Trials (ACTIVE) Workgroup . Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population. Drug Alcohol Depend. 2019 197:228-235. Epub 2019 Feb 14.
Knox J, Wall M, Witkiewitz K, Kranzler HR, Falk DE, Litten R, Mann K, O'Malley SS, Scodes J, Anton R, Hasin DS, Alcohol Clinical Trials (ACTIVE) Workgroup . Reduction in non-abstinent World Health Organization (WHO) drinking risk levels and drug use disorders: 3-year follow-up results in the US general population. Drug Alcohol Depend. 2019 201:16-22. Epub 2019 May 29.
Witkiewitz K, Falk DE, Litten RZ, Hasin DS, Kranzler HR, Mann KF, O'Malley SS, Anton RF. Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial. Alcohol Clin Exp Res. 2019 43(5):979-986. Epub 2019 Apr 5.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de